ASH 2019 | AALL0631: lestaurtinib for infant ALL

Name: AALL0631: lestaurtinib for infant ALL
Uploaded: 2019-12-07T00:00:00.000Z
Duration: 2 min 31 s
Description: Patrick Brown, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, discusses the results from the AALL0631 study (NCT00557193) of infant ALL patients treated with lestaurtinib at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.

Patrick Brown • 7 Dec 2019

ASH 2019

Acute Lymphoblastic Leukemia Leukemia Lestaurtinib

AALL0631

Patrick Brown, MD, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, discusses the results from the AALL0631 study (NCT00557193) of infant ALL patients treated with lestaurtinib at the American Society of Hematology (ASH) 2019 Annual Meeting and Exposition in Orlando, FL.